1 |
D.H. Roukos, Current status and future perspectives in gastric cancer management, Cancer Treat Rev., 26, 243-255 (2000)
DOI
ScienceOn
|
2 |
L. Lim, M. Michael, G.B. Mann and T. Leong, Adjuvant therapy in gastric cancer, J. Clin. Oncol., 23, 6220-6232 (2005)
DOI
ScienceOn
|
3 |
J.A. Meyerhardt and C.S. Fuchs, Chemotherapy options for gastric cancer, Semin Radiat Oncol., 12, 176-186 (2002)
DOI
ScienceOn
|
4 |
A.D. Wagner, W. Grothe, S. Behl, G. Kleber, A. Grothey, J. Haerting and W.E. Fleig, Chemotherapy for advanced gastric cancer, Cochrane Database of Systemic reviews, (2005)
|
5 |
Q.S. Shao, Z.Y. Ye, Z.Q. Ling and J.J. Ke, Cell cycle arrest and apoptotic cell death in cultured human gastric carcinoma cells mediated by arsenic trioxide, World J. Gastroenterol., 14, 3451-3456 (2005)
|
6 |
Y.F. Xiao, S.X.. Liu, D.O. Wu, X. Chen and L.F. Ren, Inhibitory effect of arsenic trioxide on angiogenesis and expression of vascular endothelial growth factor in gastric cancer, World J. Gastroenterol., 28, 5780-5786 (2006)
|
7 |
T.C. Chou and P. Talalay, Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors, Adv. Enzyme Regul., 22, 27-55 (1984)
DOI
ScienceOn
|
8 |
B. Kong, S. Huang, W. Wang, D. Ma, X. Qu, J. Jiang, X. Yang, Y. Zhang, B. Wang, B. Cui and Q. Yang, Arsenic trioxide induces apoptosis in cisplatin-sensitive and -resistant ovarian cancer cell lines, Int. J. Gynecol. Cancer., 15, 872-877 (2005)
DOI
ScienceOn
|
9 |
W.M. Cheung, P.W. Chu and Y.L. Kwong, Effects of arsenic trioxide on the cellular proliferation, apoptosis and differentiation of human neuroblastoma cells, Cancer Lett., 8, 122-128 (2007)
|
10 |
M.T. Park, Y.H. Kang, I.C. Park, C.H. Kim, Y.S. Lee, H.Y. Chung and S.J. Lee, Combination treatment with arsenic trioxide and phytosphingosine enhances apoptotic cell death in arsenic trioxide-resistant cancer cells, Mal. Cancer Ther., 6, 82-92 (2007)
DOI
ScienceOn
|
11 |
H.O. Jin, S.I. Yoon, S.K. Seo, H.C. Lee, S.H. Woo, D.H. Yoo, S.J. Lee, T.B. Choe, S. An, T.J. Kwon, J.I. Kim, M.J. Park, S.I. Hong, I.C. Park and C.H. Rhee, Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin, Biochem. Pharmacol., 15, 1228-1236 (2006)
|
12 |
L.M. Lin, B.X. Li, J.B. Xiao, D.H. Lin and B.E. Yang, Synergistic effect of all-trans-retinoic acid and arsenic trioxide on growth inhibition and apoptosis in human hepatoma, breast cancer, and lung cancer cells in vitro, World J. Gastroenterol., 28, 5633-5637 (2005)
|
13 |
M.J. Park, I.C. Park, I.J. Bae, K.M. Seo, S.H. Lee, S.I. Hong, C.K. Eun, W. Zhang and C.H. Rhee, Tetraarsenic oxide, a novel orally administrable angiogenesis inhibitor, Int. J. Oncol., 22, 1271-1276 (2003)
|
14 |
L.C. Park, M.J. Park, S.H. Woo, R.C. Lee, S. An, H.S. Gwak, S.H. Lee, S.I. Hong, I.J. Bae, K.M. Seo and C.H. Rhee, Tetraarsenic oxide induces apoptosis in U937 leukemic cells through a reactive oxygen species-dependent pathway, Int. J. Oncol., 23, 943-948 (2003)
|
15 |
J.L. Au, D. Li, Y Gan, X. Gao, A.L. Johnson, J. Johnston, N.J. Millenbaugh, S.H. Jang, H.J. Kuh, C.T. Chen and M.G Wientjes, Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention, Cancer Res., 15, 2141-2148 (1998)
|